CASE STUDY #1 . The student nurse has to administer antibiotics to a patient who has developed a complicated GU infection. The antibiotics that the student nurse has to administer to the patient include ertapenem, cefaclor, and ciprofloxacin.( learning objectives 1,2,and 4). (A). The faculty member asks the student nurse to explain how an antibiotics is selected for use in a particular clinical situation. what should the student nurse tell the faculty member about how antibiotic is selected? (B). What are the common adverse effects of ertapenem, cefaclor, and ciprofloxacin that the student nurse needs to tell the patient about?(C).what specific points should the student nurse include in patient teaching about ertapenem, cefaclor and ciprofloxacin?
CASE STUDY#2. A patient is being treated with combination antiviral drugs for HIV and locally active antiviral drugs that include zidovudine and acyclovire. the student is preparing a 5- minute presentation on antiviral agents for clinical preconference. The student has to prepare medication information about the antiviral medications that are being administered to the client'( learning objective 2,3,and 5). (A).what are the key characteristics of common viral infections? (B).what are the common adverse effects of zidovudine? (C).what key nursing considerations should the nurse focus on for the patient receiving a locally active antiviral agent?
CASE STUDY#3. An adult patient and two school-age children have recently returned from 2 months in Africa .While in Africa, the patient misplaced the preventive medication for malaria.( learning objective 1,2,3, and 5). (A). What is the life cycle of the protozoan that causes malaria? (B). What is the goal of treatment for malaria?(C). What are the common adverse reactions of drugs used to treat malaria? (D). What other common protozoal infections, including cause and clinical presentation, could this patient develop from the trip abroad? (E). What are the key nursing considerations for the adult patient and two school-age children who have been receiving an antiprotozoal agent?